Navigation Links
More Evidence That Vaccines Don't Cause Autism
Date:9/13/2010

By Jenifer Goodwin
HealthDay Reporter

MONDAY, Sept. 13 (HealthDay News) -- Infants exposed to the highest levels of thimerosal, a mercury-laden preservative that used to be found in many vaccines, were no more likely to develop autism than infants exposed to only a little thimerosal, new research finds.

The study offers more reassurance to parents who worry that vaccination raises their children's risk for autism, the researchers said.

"Prenatal and early life exposure to ethylmercury from thimerosal in vaccines or immunoglobulin products does not increase a child's risk of developing autism," concluded senior study author Dr. Frank DeStefano, director of the immunization safety office at the U.S. Centers for Disease Control and Prevention.

The study was released online Sept. 13 in advance of publication in the October print issue of Pediatrics.

Thimerosal has been used as a preservative in vaccines since the 1930s, according to background information in the article.

Concerns about the chemical began to crop up in 1999, when the U.S. Food and Drug Administration said that because of the increased number of thimerosal-containing vaccines added to the infant vaccination schedule, infants may be exposed to too much mercury. Thimerosal used to be found in hepatitis B, Hib (Haemophilus influenzae type B) and DTP (diphtheria, tetanus, pertussis) vaccines, among others.

During the ensuing years, the FDA worked with manufacturers to eliminate thimerosal from vaccines, according to the agency's Web site. Today, thimerosal has been removed or reduced to trace amounts in all vaccines routinely recommended for children 6 years of age and younger, with the exception of inactivated seasonal flu vaccine, according to the FDA. Parents who are concerned about thimerosal can ask for a preservative-free version, DeStefano said.

And thimerosal wasn't the only proposed autism-vaccine link. A 1998 paper in The Lancet suggested the MMR (measles-mumps-rubella) vaccine might trigger autism. The journal later retracted the paper, and numerous studies have refuted any link between the MMR vaccine and autism.

In February of 2009, a U.S. federal court ruled that there was no scientific evidence linking vaccines to autism.

In the new study, researchers examined medical records and conducted interviews with the mothers of 256 children with an autism spectrum disorder and 752 children matched by birth year who did not have autism. The children were all members of three health care management organizations in California and Massachusetts.

Researchers also gathered information about the manufacture and lot number of the vaccines that the children received, to determine how much thimerosal they were likely exposed to.

Children in the highest 10 percent of thimerosal exposure, either prenatally or between infancy and 20 months, were no more likely to have autism, an autism spectrum disorder or autism spectrum disorder with regression than children in the lowest 10 percent of exposure.

"This study adds to a large body of evidence indicating that early thimerosal exposure through vaccination does not cause autism," said Geraldine Dawson, chief science officer for a leading advocacy group, Autism Speaks. Dawson was not involved with the research.

She urged parents to have their children vaccinated.

"We encourage parents to have their children vaccinated and to establish a trusting relationship with their child's pediatrician so they can discuss any concerns they have," Dawson said.

More information

The U.S. Food and Drug Administration has more on thimerosal.

SOURCES: Frank DeStefano, M.D., M.P.H., director, immunization safety office, U.S. Centers for Disease Control and Prevention; Geraldine Dawson, Ph.D., chief science officer, Autism Speaks, New York City; Sept. 13, 2010, Pediatrics, online


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New research finds evidence of charitable behavior in bacteria
2. More Evidence Virus Plays Role in Chronic Fatigue Syndrome
3. Autism: Lack of evidence for antidepressants
4. New research finds no evidence that popular slimming supplements facilitate weight loss
5. More Evidence That B Vitamins Alone Wont Counter Heart Risks
6. New evidence that smokeless tobacco damages DNA and key enzymes
7. Experts explore emerging evidence linking diabetes and cancer
8. New evidence that drinking coffee may reduce the risk of diabetes
9. New evidence that chili pepper ingredient fights fat
10. Mobile access now available for Essential Evidence Plus
11. New evidence caffeine may slow Alzheimers disease and other dementias, restore cognitive function
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
More Evidence That Vaccines Don't Cause Autism
(Date:2/24/2017)... ... 24, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of ... generation. Yisrayl makes an astounding statement when he says that the entire Bible ... Bible details the current times so plainly that anyone should be able to see ...
(Date:2/24/2017)... Lawn, NJ (PRWEB) , ... February 24, 2017 ... ... with robust marketing services, which specializes in thought leadership , media relations, ... marketing campaigns and services that will be powered through Act-On, an intuitive marketing ...
(Date:2/23/2017)... MA (PRWEB) , ... February 23, 2017 , ... ... and Department of Justice jointly issued a letter to withdraw previous ... accordance with their gender identity. The guidance issued in May 2016 by the ...
(Date:2/23/2017)... NC (PRWEB) , ... February 23, 2017 , ... The ... Sponsor for ACPA’s 74th Annual Meeting. KLS is a longtime supporter of the ... as an exhibitor and Platinum Sponsor," said Dr. Bob Havlik, 2017 ACPA President. "KLS ...
(Date:2/23/2017)... Mass. (PRWEB) , ... February 23, 2017 , ... ... as an approved content provider for the National Institute for Health and ... and social care-related organizations in the National Health Service (NHS) to search, order ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
(Date:2/23/2017)... 2017 Visiomed, the French leader in ... is changing the landscape of healthcare with their ... pro-active, custom-made solutions. Recognizing the rising demand of ... healthcare without walls, Visiomed has launched BewellConnect, the ... healthcare professionals that is empowering the lives of ...
(Date:2/23/2017)... , Feb. 23, 2017  Genesis Healthcare Services has ... announcement was made by Bill Monast , President ... and Nathan Feltman , executives with Home ... Services, LLC. This acquisition helps Hospice ... of technology enabled durable medical equipment (DME) solutions for ...
Breaking Medicine Technology: